GSK’s Shingrix is latest drug to show potential for targeting previously untreatable brain disorders
Pascal Soriot criticises decision to block breast cancer drug in England as FTSE 100 group raises profit outlook
Long waiting list for drug because of shortage of specialist services could hit patients unable to pay privately
Pharma groups could see almost threefold drop in demand due to US health official decision, says Airfinity
Swiss drugmaker says it will only sell medication privately if health systems cannot pay
While French leftists demand the premiership, the president faces fissures in his own camp
Leftist parties are united in rejecting President Emmanuel Macron but divided on much else
Explore France’s snap election for the National Assembly in maps and charts
Nouveau Front Populaire bloc won the most parliamentary seats in snap election but fell short of majority
A hastily assembled leftist bloc beat back the challenge from Marine Le Pen’s RN — for now
Marine Le Pen’s Rassemblement National falls well short of expected gains in parliament
Complicated talks lie ahead after snap elections result in hung parliament
Ipsos projects a closer race likely to result in a hung parliament
UK pharma body criticises maker of Ozempic and Wegovy over failure to report £7.8mn in transfers of value
Sunday’s run-off vote viewed with apprehension in both communities
Political chaos dents France’s image and raises security issues at world’s most-watched sporting event
Shares in London-listed maker of medical devices jump as holdings disclosed
New agreement hands UK drugmaker control of developing jabs and provides cash injection for German group
Pfizer and BioNTech infringed pharmaceutical group’s mRNA patent, High Court in London rules
Raphaël Glucksmann says voters must act to block far right from taking power
Stocks and euro rise as some second-round candidates could be pulled to try to boost vote against Rassemblement National
Far-right Rassemblement National has broadened its appeal but its path to a majority remains uncertain
President Emmanuel Macron’s centrists fall to third place behind leftwing alliance
Pharma group dealt another blow following decision by British to award vaccine contract to rival Pfizer
Also in this newsletter: some (rare) good news for the EU’s Liberals